21 results
8-K
EX-2.1
SEEL
Seelos Therapeutics Inc
19 Feb 19
Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
8:00am
425
EX-2.1
SEEL
Seelos Therapeutics Inc
16 Jan 19
Business combination disclosure
12:00am
8-K
EX-2.1
SEEL
Seelos Therapeutics Inc
16 Jan 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
SEEL
Seelos Therapeutics Inc
14 Dec 18
Entry into a Material Definitive Agreement
4:48pm
425
EX-2.1
SEEL
Seelos Therapeutics Inc
14 Dec 18
Business combination disclosure
4:46pm
8-K
EX-2.1
skn681lcxx1djo15 ot
16 Oct 18
Entry into a Material Definitive Agreement
8:57pm
425
EX-2.1
p3r7tnb60
16 Oct 18
Business combination disclosure
8:56pm
8-K
EX-2.1
zkkg6e
20 Sep 18
Entry into a Material Definitive Agreement
9:43pm
8-K
EX-2.1
knj60bq
30 Jul 18
Entry into a Material Definitive Agreement
12:00am
425
EX-2.2
txb 5ckjgqklt
30 Jul 18
Business combination disclosure
12:00am
425
EX-2.1
4p8bo4k
30 Jul 18
Business combination disclosure
12:00am
425
EX-2.3
3retu
30 Jul 18
Business combination disclosure
12:00am
8-K
EX-2.2
dsn63d8
30 Jul 18
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.3
m5c42jgcw 4mcjnjw
30 Jul 18
Entry into a Material Definitive Agreement
12:00am
SC 13D
EX-2
fnje1p5
23 Feb 15
Beneficial ownership report
12:00am
8-K
EX-2.1
77o0qi10 2r
1 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
gdhe9q 64
13 Jul 12
Completion of Acquisition or Disposition of Assets
12:00am
8-K
EX-2.1
wk4azznk9hx2
6 Jul 11
Completion of Acquisition or Disposition of Assets
12:00am